header-logo
Physicians Collaborate Whiteboard
Residency Program

Medical College of Wisconsin Department of Medicine Resident Scholarship Program

Medicine Residency Scholarship Program

All our residents have the opportunity to do research while at MCW and participate in multiple longitudinal programs to support their success.

Program leadership works with all residents who wish to participate in research and has the following resources available:

  • Month-long research elective as PGY2 or PGY3 if they have a project that would benefit from dedicated time
  • In-house free statistical support with Department of Medicine, including PhD and masters-level statisticians
  • Funding through the Department of Medicine to support resident travel to present research results at meetings

Longitudinal Curriculum for Advanced Scholarship (LOCAS) Program

All categorical residents who wish to pursue high impact projects are invited to participate in the Longitudinal Curriculum for Advanced Scholarship (LOCAS) program, which is directed by Dr. Carlson and Dr. Putman. Details of the LOCAS program:

  • Optional mentored two-year program that launches in October of the PGY1 year and concludes in July of the PGY3 year.
  • Sixteen accomplished faculty researchers in various “Focus Areas” provide direct mentorship or facilitate mentorship relationships with each resident in their area of interest. Focus Areas include medical specialties such as cardiology and hematology/oncology as well as general medicine and quality improvement.
  • During year one, residents participate in didactic sessions about how to design successful resident research projects, perform background research, submit institutional review board applications, and collect and analyze data.
  • Year two provides asynchronous content about how to write publishable manuscripts, submit them to academic journals, present findings at national meetings, and navigate the revise and resubmit process.
  • Residents present their projects at the annual Department of Medicine Research Day and at the American College of Physicians Annual Abstract Competition.
  • Those who complete the program receive a certificate of completion and recognition for their hard work.

Unique to the medicine residency program at MCW is an experiential quality improvement curriculum that stretches through the duration of the program under the directorship of residency program leadership and Dr Wainaina, vice chair for clinical quality. It comprises:

  • PGY1: Didactic sessions during which interns learn basic healthcare quality principles and improvement skills that they use to identify and plan improvement projects for patients under their care with mentorship by PGY3s.
  • PGY2: Deployment of proposed projects with data support from a dedicated departmental quality and operations team.
  • PGY3: PGY1 mentoring, project wrap-up, report-out, scholarly dissemination and if appropriate hand-off for continuity.

Recent Resident Research Publications

Adam Devine, Jacob Jewulski, Morgan Lamberg
Degenerative Mitral Stenosis: a case-based review

Ben Massat
Association of Human Leukocyte Antigen Variants with Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma

Carson Castellani
Left Atrial Appendage Structural Characteristics Predict Thrombus Formation

Transbronchial Lung Cryobiopsy is Safe and Effective for Diagnosing Acutely Ill Hospitalized Patients with New Diffuse Parenchymal Lung Disease

Cody Bruggemeyer
Unintentional Unblinding in Rheumatic Disease Trials Accepted – Lancet Rheumatology

Lauren Hipp
High-Dose IV Hydroxocobalamin (Vitamin B12) in Septic Shock: A Double-Blind, Allocation-Concealed, Placebo-Controlled Single-Center Pilot Randomized Controlled Trial (The Intravenous Hydroxocobalamin in Septic Shock Trial)

Sara Tesfatsion and Jennifer Woodard
Faculty Physician and Trainee Experiences with Micro- and Macroaggressions: a Qualitative Study

Sonya Dave
Management Strategies for Obesity Vary for Patients with Inflammatory Bowel Disease

Shabi Haider
Chimeric Antigen Receptor-T (CAR-T) Cell Therapy Targeting BCMA in Patients with Prior Allogenic Transplantation (allo-HCT) in Relapsed and/or Refractory Multiple Myeloma (RRMM)

Skyler Taylor
Re-induction with venetoclax combinations or IDH inhibitors result in similar remission rates and lower treatment related morbidity among AML patients initially receiving intensive induction chemotherapy

Medicine Residency Scholarship Program Gupta

Medicine Residency Scholarship Program Held Baumann

© 2025 Medical College of Wisconsin.  All rights reserved.  | Terms and Privacy | Web Accessibility Statement

Non-Discrimination, Anti-Harassment, and Legal Compliance Statement
The Medical College of Wisconsin (MCW) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, military status, or other legally protected classification. MCW maintains full compliance with all applicable federal, state, and local laws and regulations in pursuit of our missions. Consistent with federal guidance, we affirm our commitment to individual merit, fairness, and equal treatment in all aspects of academic and institutional decision-making.

MCW's policies, federal and state laws, and regulations prohibit unlawful discrimination and harassment. Employees, learners, students, applicants, or other members of the MCW community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic.